Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Santa Barbara, California 93105


Purpose:

This trial is conducted in the United States of America (USA). The purpose of this study is to test whether NovoLog (insulin aspart) is a safe and at least as effective alternative to regular human insulin for the control of blood glucose after meals in women who develop diabetes during pregnancy.


Criteria:

Inclusion Criteria: - Subjects older than 35 years old will be considered - Gestational diabetes mellitus


NCT ID:

NCT00065130


Primary Contact:

Study Director
Global Clinical Registry (GCR, 1452)
Novo Nordisk A/S


Backup Contact:

N/A


Location Contact:

Santa Barbara, California 93105
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 14, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.